Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada

par Lachaine, Jean, Beauchemin, Catherine, Mathurin, Karine, Gilbert, Dominique, Beillat, Maud
Publié 2014

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK

par Moore, Lee, Remy, Vanessa, Martin, Monique, Beillat, Maud, McGuire, Alistair
Publié 2010

Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed t...

par Majer, Istvan M., Gaughran, Fiona, Sapin, Christophe, Beillat, Maud, Treur, Maarten
Publié dans J Mark Access Health Policy (2015)

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

par Sapin, Christophe, Hartry, Ann, Kamat, Siddhesh A., Beillat, Maud, Baker, Ross A., Eramo, Anna
Publié dans Drugs Context (2016)

Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

par Nguyen-Thi, Hai-Yen, Nguyen, Nga TQ., Le, Nguyen Dang Tu, Beillat, Maud, Ethgen, Olivier
Publié dans Front Public Health (2020)

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study

par Serradell Laurence, Beillat Maud, Naldi Luigi, Gatti Antonio, Pezzotti Patrizio, Merito Monica, Gialloreti Leonardo, di Marzo Rafaelle, Volpi Antonio
Publié 2010-08-01

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study

par Gialloreti, Leonardo Emberti, Merito, Monica, Pezzotti, Patrizio, Naldi, Luigi, Gatti, Antonio, Beillat, Maud, Serradell, Laurence, di Marzo, Rafaelle, Volpi, Antonio
Publié 2010

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

par Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A., Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Steen Andersen, Henrik, Eramo, Anna, Hansen, Karina, Naber, Dieter
Publié dans Int Clin Psychopharmacol (2017)

Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

par Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A, Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Nitschky Schmidt, Simon, Eramo, Anna, Hansen, Karina, Naber, Dieter
Publié dans Int J Neuropsychopharmacol (2016)

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

par Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A., Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Nitschky Schmidt, Simon, Ettrup, Anders, Eramo, Anna, Hansen, Karina, Naber, Dieter
Publié dans PLoS One (2017)

PM417. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning: a post-hoc analysis of QUALIFY, a head-to-head study...

par Salzman, Phyllis, Baker, Ross A., Beillat, Maud, Eramo, Anna, Forray, Carlos, Hansen, Karina, Hertel, Peter, Loze, Jean-Yves, Naber, Dieter, Schmidt, Simon Nitschky, Nylander, Anna-Greta, Peters-Strickland, Timothy, Potkin, Steven G., Sapin, Christophe
Publié dans Int J Neuropsychopharmacol (2016)